$0.69
4.55% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$0.69
-0.04 5.48% 1M
-0.09 11.54% 6M
-0.10 12.22% YTD
-1.07 60.80% 1Y
-5.50 88.85% 3Y
-6.31 90.14% 5Y
-124.59 99.45% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.03 4.55%
ISIN
US23725P1003
Symbol
DRIO
Sector

Key metrics

Market capitalization $30.33m
Enterprise Value $32.62m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.16
P/S ratio (TTM) P/S ratio 1.08
P/B ratio (TTM) P/B ratio 0.40
Revenue growth (TTM) Revenue growth 47.21%
Revenue (TTM) Revenue $28.03m
EBIT (operating result TTM) EBIT $-49.16m
Free Cash Flow (TTM) Free Cash Flow $-32.24m
Cash position $28.05m
EPS (TTM) EPS $-0.88
P/E forward negative
P/S forward 0.94
EV/Sales forward 1.01
Short interest 7.16%
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a DarioHealth Corp. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a DarioHealth Corp. forecast:

Buy
75%
Hold
25%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
28 28
47% 47%
100%
- Direct Costs 13 13
3% 3%
48%
15 15
180% 180%
53%
- Selling and Administrative Expenses 34 34
13% 13%
121%
- Research and Development Expense 22 22
0% 0%
77%
-41 -41
26% 26%
-146%
- Depreciation and Amortization 8.26 8.26
52% 52%
29%
EBIT (Operating Income) EBIT -49 -49
19% 19%
-175%
Net Profit -32 -32
35% 35%
-115%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
Seeking Alpha
7 days ago
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dodo - Acting Chief Operating Officer Conference Call Participants Charles Yi - TD Securities David Grossman - Stifel Nicolaus Operator Good morning, ladies and gentlemen, and welcome to the DarioHeal...
Neutral
PRNewsWire
7 days ago
First quarter revenue of $6.75 million, a 17% increase year-over-year, driven by employer and health plan (B2B2C) growth, and a decrease of 11% sequentially. Gross margin increased to 57.5% compared to 42.2% in the first quarter of 2024 Gross margin (non-GAAP) increased to 70.5%, up from 62.4% in the first quarter of 2024 Operating expenses decreased by 35% compared to the first quarter of 2024...
Neutral
PRNewsWire
13 days ago
New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW YORK , May 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research published in the Journal of Medical Internet Research ("JMIR") demonstrating the eff...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 202
Founded 2011
Website www.dariohealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today